CliffBio
small molecule

QUDEXY XR

TOPIRAMATE

Loss of exclusivityMarch 2033latest FDA-listed patent expiry
CompanyUPSHER SMITH LABORATORIES LLC

Drug detail

Brand nameQUDEXY XR
Active ingredientTOPIRAMATE
Strength50MG
Dosage formCAPSULE, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalMarch 2014
Marketing statusRX

Listed patents

PatentExpiresType
10363224March 2033use U-766
9555005March 2033product
8889190March 2033product
8652527March 2033product
9101545March 2033product

More from UPSHER SMITH LABORATORIES LLC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

QUDEXY XR patent cliff — loss of exclusivity March 2033 | CliffBio